The J. M. Smucker Company
SJM - NYSE - $99.25 ▼ -%0.19
-
Earnings Tue 9 Jun
Note: this preview was published before the 2026-06-09 earnings report. Results have since been released — verify against the latest filings.

J. M. opens the
books on Tuesday evening.

7 analysts' median target is $119[FMP target], stock is $99, +19.4% upside potential. After Q2 +4.8% EPS beat[FMP earnings], the stock moved -0.0%.

summary below
Quick Take - in 40 seconds
C+
BUY Council 1/6 - Moonshot 47

C+ = MoonshotScore 47[9-pillar formula] + Council 1/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $2.3B[FMP est], EPS $2.66[FMP est]. 1 consecutive quarters of beat[FMP earnings].

$2.66 EPS Estimate Last year $2.31 - +15% YoY YoY
1 Beat Streak Expectations beaten consecutively for the last 1 quarters

Q2 EPS +4.8% beat[FMP] but the stock -0.0% D+1[FMP D+1]. Tucker Marshall promised $71.5M CapEx + a sequential decline in Q4 during the Q2 earnings call[Tucker Marshall capex transcript].

Watchlist

5 metrics stand out this quarter.

$9 Investor Focus

Fy27 Eps Growth

fy27_eps_growth

With a stabilizing commodity environment and an off-tariff environment, as we continue to generate cash and pay down debt and we deliver a level of business momentum, there could be a path to that.

"But the essence that we are trying to communicate is that with a stabilizing commodity environment and an off-tariff environment, as we continue to generate cash and pay down debt and we deliver a level of business momentum, there could be a path to that, and that's what we were trying to just lay out as you think about a $9 midpoint at this fiscal year."

- Tucker Marshall, CFO - Q2 FY26 Earnings Call - November 25, 2025
$0.50 Investor Focus

Tariff Impact Fy27

tariff_impact_fy27

Stepping into FY 2027, the $0.50 impact related to green coffee tariffs should be viewed as a tailwind, while in FY 2026, it continues to be a headwind.

"Andrew, good morning. The predominance of the $0.50, if not all, is related to green coffee tariffs. And so, therefore, stepping into FY 2027, it should be viewed as a tailwind while in FY 2026, it continues to be a headwind."

- Tucker Marshall, CFO - Q2 FY26 Earnings Call - November 25, 2025
- Investor Focus

Pet Portfolio Growth

pet_portfolio_growth

We are anticipating low single-digit growth for our pet portfolio in the third and fourth quarters behind the momentum of Milk Bone and Meow Mix.

"Rob, in support of your question, we are anticipating low single-digit growth for our pet portfolio in the third and fourth quarters behind the momentum of Milk Bone and Meow Mix."

- Tucker Marshall, CFO - Q2 FY26 Earnings Call - November 25, 2025
25% Investor Focus

Sweet Baked Snacks Improvement

sweet_baked_snacks_improvement

We are pleased with the progress in Sweet Baked Snacks and the Hostess brand, noting improved performance in c-store and improving volume shares.

"First, we are very pleased with the progress that we're making on Sweet Baked Snacks and the Hostess brand. As you noted, we are seeing sequential improvement. Notably, we're seeing improved performance in c-store. Our volume shares are improving."

- Mark Smucker, CEO - Q2 FY26 Earnings Call - November 25, 2025
- Investor Focus

Uncrustables Billion Dollar Brand

uncrustables_billion_dollar_brand

I can tell you that it still demonstrates growth and it is demonstrating a path or trajectory to being a billion-dollar brand by the end of this fiscal year.

"Much of that is driven by the spreads portfolio, and we really haven't taken up the outlook on the Uncrustables brand. I can tell you that it still demonstrates growth and it is demonstrating a path or trajectory to being a billion-dollar brand by the end of this fiscal year."

- Tucker Marshall, CFO - Q2 FY26 Earnings Call - November 25, 2025

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 1 / 6 Bullish

6 investor frameworks. 1 bullish (Ray Dalio), 1 bearish (Ken Griffin), 4 neutral (Jim Simons, Klarman, Buffett, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +19.4%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 58
Klarman value - target upside +19.4%
Buffett quality - ROE score 1/5
Munger valuation - target upside +19.4%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthWeak
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCTight
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
58.2 RSI 58.2 positive momentum, 50d below
MACD
-0.20 price below 50d - resistance dominant
50d MA
$99 stock 0.2% below - short-term resistance
200d MA
$104 stock 4.8% below - long-term pressure
Volume (10d)
-6% decrease - low participation
Resistance
$119
Analyst median target - upgrade trigger if broken
Current
$99
Pre-earnings position
Support
$89
Invalidation - close below this is a technical breakdown
Pattern
Range
$89-$119 band - earnings breakout/breakdown trigger

Past Performance

The's last 8 quarters: 1 consecutive beats.

BEAT
Q4 FY25
$2.31 vs $2.24 est - +1.5%
MISS
Q1 FY26
$1.90 vs $1.93 est - +1.0%
MISS
Q2 FY26
$2.10 vs $2.10 est - +2.8%
BEAT
Q3 FY26
$2.38 vs $2.27 est - -0.0%

Q2 (November 25, 2025): EPS $2.38 vs $2.27 est[FMP], +4.8% beat. D+1 movement: -0.0%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $2.58 (no guidance)

Q2: EPS $2.38 vs $2.27 beat[FMP], stock -0.0% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q2 earnings call.

CapEx shock

Q2 CapEx $71.5M[FMP cashflow]. Q2 op margin 20.2%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $2.66 + CapEx discipline
Threshold: EPS > $2.66[FMP est].
Target: Break above median target $119[FMP target]; high target $134[FMP] upper bound.
Scenario B - In-Line
EPS approx $2.66 + CapEx < $71.5M
Threshold: EPS approx $2.66[FMP est], Q4 CapEx < $71.5M[FMP].
Target: Consolidation in the band between current $99[FMP] and median $119[FMP].
Scenario C - Miss
EPS < $2.58 or CapEx >= $71.5M
Threshold: EPS < $2.58[FMP estx0.97].
Target: Current $99 below SMA200 $104[FMP], if rejection continues, $89[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 7 analysts say?

Wall Street Consensus
$119
12-month median target price (+19.4% upside potential)
10
BUY
10
HOLD
0
SELL
Risk Management
$89
Invalidation level - critical support threshold
$99 - 50-day MA (below, -0.2%)
$104 - 200-day MA (below, -4.8%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - SJM Q4 FY26
C+

You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Tuesday evening. The framework is ready on this page: Q4 EPS threshold $2.66[FMP], CapEx threshold "below $71.5M"[Tucker Marshall]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jun 9, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jun 10, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Jul 24, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Sep 9, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the SJM earnings preview cover?

This SJM (SJM) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in SJM earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.